Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells for severe aplastic anemia: Successful engraftment and mild GVHD

Stem Cell Research

Volumn 12, Issue 1, 2014, Pages 132-138

  Wu, Yamei ^a   Cao, Yongbin ^a   Li, Xiaohong ^a   Xu, Lixin ^a   Wang, Zhihong ^a   Liu, Pei ^a   Yan, Pei ^a   Liu, Zhouyang ^a   Wang, Jing ^a   Jiang, Shuang ^a   Wu, Xiaoxiong ^a   Gao, Chunji ^a   Da, Wanming ^a   Han, Zhongchao ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUDARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHIMERA; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; T CELL DEPLETION; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION, HOMOLOGOUS; UMBILICAL CORD; YOUNG ADULT;

EID: 84886675301     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.10.001     Document Type: Article

References (30)

1. Atkinson K., Horowitz M.M., Gale R.P., Lee M.B., Rimm A.A., Bortin M.M. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant. 1989, 4:247-254.
2. Bacigalupo A., Brand R., Oneto R., Bruno B., Socié G., Passweg J., Locasciulli A., Van Lint M.T., Tichelli A., McCann S., Marsh J., Ljungman P., Hows J., Marin P., Schrezenmeier H. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience. Semin. Hematol. 2000, 37:69-80.
3. Ball L.M., Bernardo M.E., Roelofs H., Lankester A., Cometa A., Egeler R.M., Locatelli F., Fibbe W.E. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007, 110:2764-2767.
4. Bensinger W.I., Martin P.J., Storer B., Clift R., Forman S.J., Negrin R., Kashyap A., Flowers M.E., Lilleby K., Chauncey T.R., Storb R., Appelbaum F.R. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N. Engl. J. Med. 2001, 344:175-181.
5. Camitta B.M., Thomas E.D., Nathan D.G., Gale R.P., Kopecky K.J., Rappeport J.M., Santos G., Gordon-Smith E.C., Storb R. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979, 53:504-514.
6. De Medeiros C.R., Bitencourt M.A., Medeiros B.C., Ioshizumi L., Pasquini R. Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases. Bone Marrow Transplant. 2001, 28:941-944.
7. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
8. Fang B., Song Y., Li N., Li J., Zhao R.C. Cotransplantation of haplo-identical mesenchymal stem cells to reduce the risk of graft failure in a patient with refractory severe aplastic anemia. Acta Haematol. 2008, 119:162-165.
9. Fang B., Li N., Song Y., Li J., Zhao R.C., Ma Y. Cotransplantation of haplo-identical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatr. Transplant. 2009, 13:499-502.
10. Guo M., Sun Zh., Sun Q.Y., Han Q., Yu C.L., Wang D.H., Qiao J.H., Chen B., Sun W.J., Hu K.X., Liu G.X., Liu B., Zhao R.Ch., Ai H.S. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD. Biol. Blood Marrow Transplant. 2009, 15:930-937.
11. In't Anker P.S., Noort W.A., Scherjon S.A., Kleijburg-van der Keur C., Kruisselbrink A.B., van Bezooijen R.L., Beekhuizen W., Willemze R., Kanhai H.H., Fibbe W.E. Mesenchymal stem cells in human second trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003, 88:845-852.
12. Klyushnenkova E., Mosca J.D., McIntosh K.R. Human mesenchymal stem cells suppress allogeneic T cell responses in vitro: implications for allogeneic transplantation [abstract 2652]. Blood 1998, 92(Suppl. 1, part 1):642a.
13. Lazarus H.M., Koc O.N. Culture-expanded human marrow derived MSCs in clinical hematopoietic stem cell transplantation. Graft 2001, 3:329-333.
14. Lazarus H.M., Koc O.N., Devine S.M., Curtin P., Maziarz R.T., Holland H.K., Shpall E.J., McCarthy P., Atkinson K., Cooper B.W., Gerson S.L., Laughlin M.J., Loberiza F.R., Moseley A.B., Bacigalupo A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 2005, 11:389-398.
15. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
16. Le Blanc K., Frassoni F., Ball L., Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
17. Lee O.K., Kuo T.K., Chen W.M., Lee K.D., Hsieh S.L., Chen T.H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
18. Lu D.P., Dong L., Wu T., Huang X.J., Zhang M.J., Han W., Chen H., Liu D.H., Gao Z.Y., Chen Y.H., Xu L.P., Zhang Y.C., Ren H.Y., Li D., Liu K.Y. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haplo-identical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006, 107:3065-3073.
19. Lu L.L., Liu Y.J., Yang S.G., Zhao Q.J., Wang X., Gong W., Han Z.B., Xu Z.S., Lu Y.X., Liu D., Chen Z.Z., Han Z.C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006, 91:1017-1026.
20. Mickelson E., Smith A., McKinney S., Anderson G., Hansen J.A. A comparative study of HLA-DRB1 typing by standard serology and hybridization of non-radioactive sequence-specific oligonucleotide probes to PCR-amplified DNA. Tissue Antigens 1993, 41:86-93.
21. Passweg J.R., Perez W.S., Eapen M., Camitta B.M., Gluckman E., Hinterberger W., Hows J.M., Marsh J.C., Pasquini R., Schrezenmeier H., Socié G., Zhang M.J., Bredeson C. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant. 2006, 37:641-649.
22. Petersdorf E.W., Smith A.G., Mickelson E.M., Martin P.J., Hansen J.A. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991, 33:267-275.
23. Romanov Y.A., Svintsitskaya V.A., Smirnov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSClike cells from umbilical cord. Stem Cells 2003, 21:105-110.
24. Storb R., Deeg H.J., Whitehead J., Appelbaum F., Beatty P., Bensinger W., Buckner C.D., Clift R., Doney K., Farewell V. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 1986, 314:729-735.
25. Tabbara I.A., Zimmerman K., Morgan C., Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch. Intern. Med. 2002, 162:1558-1566.
26. Tsutsumi Y., Tanaka J., Miura T., Saitoh S., Yamada M., Yamato H., Ehira N., Kanamori H., Kawamura T., Obara S., Ogura N., Matsushima T., Maruya E., Asaka M., Imamura M., Saji H., Masauzi N. Successful non-T-cell-depleted nonmyeloablative hematopoietic stem cell transplantation (NST) from an HLA-haplo-identical 2-loci-mismatched sibling in a heavily transfused patient with severe aplastic anemia based on the fetomaternal microchimerism. Bone Marrow Transplant. 2004, 34:267-269.
27. Wagner J.L., Deeg H.J., Seidel K., Anasetti C., Doney K., Sanders J., Sullivan K.M., Storb R. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. Transplantation 1996, 61:54-61.
28. Wang H.X., Yan H.M., Duan L.N., Wang Z.D., Zhu L., Xue M., Liu J., Hu L.D., Guo Z.K. Haplo-identical hematopoietic stem cell transplantation in children hematologic malignancies with G-CSF mobilized marrow grafts without T cell depletion: a single center report of 45 cases. Pediatr. Hematol. Oncol. 2009, 26:119-128.
29. Woodard P., Cunningham J.M., Benaim E., Chen X., Hale G., Horwitz E., Houston J., Kasow K., Leung W., Wang W., Yusuf U., Handgretinger R. Effective donor lymphohematopoietic reconstitution after haplo-identical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia. Bone Marrow Transplant. 2004, 33:411-418.
30. Wu Y.M., Wang Z.H., Cao Y.B., Xu L.X., Li X.H., Liu P., Yan P., Liu Z.Y., Zhao D.D., Wang J., Wu X.X., Gao C.J., Da W.M., Han Z.C. Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy. Ann. Hematol. 2013, 10.1007/s00277-013-1831-0.